MATERIALS AND METHODS
The production of antibody 7E3, its radiolabeling with 1251, and use in a platelet binding assay have been described in detail before.2'3 For the present studies, antibody was purified from ascites by affinity chromatography on protein A-Sepharose, fragmented into F(ab')2 with 2% pepsin, dialyzed against 0.15 mol/L NaCI, and frozen at -20 OC3 The absence of residual intact 7E3 antibody was confirmed by polyacrylamide gel electrophoresis. Since preliminary studies showed that the off rate of 7E3 F(ab')2 fragments, like that of the intact antibody,3 is very slow, it was possible to assess the number of F(ab')2 fragments that bound to platelets in vivo. Thus, the difference in cx vivo binding of excess '231-7E3 to platelets obtained before and after infusion of the F(ab')2 fragments represented the number of F(ab')2 molecules bound in vivo.3 Platelet aggregation in response to adenosine diphosphate (ADP) was also measured before and after infusion as previously reported. 
